• This email address is being protected from spambots. You need JavaScript enabled to view it.

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.

Laher, F., Moodie, Z., Cohen, K.W., Grunenberg, N., Bekker, L.G., Allen, M., Frahm, N., Yates, N.L., Morris, L., Malahleha, M. and Mngadi, K., 2020. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines. PLoS medicine, 17(2), p.e1003038.


© 2025 The Aurum Institute. All Rights Reserved.